Evidence map›Paper›PMID 28098391›Full record

ReviewMycoses2017

Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases.

Sudhir Baswan, Gerald B Kasting, S Kevin Li, Randy Wickett, Brian Adams, Sean Eurich, Ryan Schamper

Abstract readReview
In one paragraph

Review in Mycoses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Nail Lacquer ContainingAntibiotics (Basel, Switzerland) · 2024
    Article
  11. The development of hair follicles and nail.Developmental biology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sudhir BaswanJames L. Winkle College of Pharmacy, The University of Cincinnati Academic Health Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0003-4828-6856
Gerald B KastingJames L. Winkle College of Pharmacy, The University of Cincinnati Academic Health Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-4045-6868
S Kevin LiJames L. Winkle College of Pharmacy, The University of Cincinnati Academic Health Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0001-8626-9630
Randy WickettJames L. Winkle College of Pharmacy, The University of Cincinnati Academic Health Center, Cincinnati, OH, USA.
Brian AdamsDepartment of Dermatology, College of Medicine, The University of Cincinnati Academic Health Center, Cincinnati, OH, USA.
Sean EurichAmway Corporation, Ada, MI, USA.
Ryan SchamperAmway Corporation, Ada, MI, USA.

Funding

Methods to Control Transdermal lontophoresis VariabilityR01GM063559 · NIGMS · UNIVERSITY OF UTAH · PI LI, KEVIN S. · 2003 to 2012
$2.0M
NIGMS NIH HHS R01 GM063559
6 · The paper itself

Abstract

The topical treatment of nail fungal infections has been a focal point of nail research in the past few decades as it offers a much safer and focused alternative to conventional oral therapy. Although the current focus remains on exploring the ways of enhancing permeation through the formidable nail barrier, the understanding of the nail microstructure and composition is far from complete. This article reviews our current understanding of the nail microstructure, composition and diseases. A few of the parameters affecting the nail permeability and potential causes of the recurrence of fungal nail infection are also discussed.

Indexed as

Administration, TopicalAntifungal AgentsHumansHydrogen-Ion ConcentrationMicroscopy, Electron, ScanningNailsOnychomycosisPermeabilityAntifungal Agentsanti-fungaliontophoresiskeratinlaser treatmentnailsonychomycosis

Identifiers

PMID28098391
PMCPMC5383514

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.